396 related articles for article (PubMed ID: 33007258)
1. A High-Resolution Map of Human Enhancer RNA Loci Characterizes Super-enhancer Activities in Cancer.
Chen H; Liang H
Cancer Cell; 2020 Nov; 38(5):701-715.e5. PubMed ID: 33007258
[TBL] [Abstract][Full Text] [Related]
2. Inflammation-sensitive super enhancers form domains of coordinately regulated enhancer RNAs.
Hah N; Benner C; Chong LW; Yu RT; Downes M; Evans RM
Proc Natl Acad Sci U S A; 2015 Jan; 112(3):E297-302. PubMed ID: 25564661
[TBL] [Abstract][Full Text] [Related]
3. Genetic, Pharmacogenomic, and Immune Landscapes of Enhancer RNAs Across Human Cancers.
Zhang Z; Luo M; Li Q; Liu Y; Lussier C; Zhang J; Ye Y; Guo AY; Han L
Cancer Res; 2022 Mar; 82(5):785-790. PubMed ID: 35022213
[TBL] [Abstract][Full Text] [Related]
4. HPSE enhancer RNA promotes cancer progression through driving chromatin looping and regulating hnRNPU/p300/EGR1/HPSE axis.
Jiao W; Chen Y; Song H; Li D; Mei H; Yang F; Fang E; Wang X; Huang K; Zheng L; Tong Q
Oncogene; 2018 May; 37(20):2728-2745. PubMed ID: 29511351
[TBL] [Abstract][Full Text] [Related]
5. Functional Enhancers As Master Regulators of Tissue-Specific Gene Regulation and Cancer Development.
Ko JY; Oh S; Yoo KH
Mol Cells; 2017 Mar; 40(3):169-177. PubMed ID: 28359147
[TBL] [Abstract][Full Text] [Related]
6. Functional roles of antisense enhancer RNA for promoting prostate cancer progression.
Pan CW; Wen S; Chen L; Wei Y; Niu Y; Zhao Y
Theranostics; 2021; 11(4):1780-1794. PubMed ID: 33408781
[No Abstract] [Full Text] [Related]
7. HeRA: an atlas of enhancer RNAs across human tissues.
Zhang Z; Hong W; Ruan H; Jing Y; Li S; Liu Y; Wang J; Li W; Diao L; Han L
Nucleic Acids Res; 2021 Jan; 49(D1):D932-D938. PubMed ID: 33119754
[TBL] [Abstract][Full Text] [Related]
8. Pig-eRNAdb: a comprehensive enhancer and eRNA dataset of pigs.
Wang Y; Jin W; Pan X; Liao W; Shen Q; Cai J; Gong W; Tian Y; Xu D; Li Y; Li J; Gong J; Zhang Z; Yuan X
Sci Data; 2024 Feb; 11(1):157. PubMed ID: 38302497
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer.
Zhang Z; Lee JH; Ruan H; Ye Y; Krakowiak J; Hu Q; Xiang Y; Gong J; Zhou B; Wang L; Lin C; Diao L; Mills GB; Li W; Han L
Nat Commun; 2019 Oct; 10(1):4562. PubMed ID: 31594934
[TBL] [Abstract][Full Text] [Related]
10. Differential activity of transcribed enhancers in the prefrontal cortex of 537 cases with schizophrenia and controls.
Hauberg ME; Fullard JF; Zhu L; Cohain AT; Giambartolomei C; Misir R; Reach S; Johnson JS; Wang M; Mattheisen M; Børglum AD; Zhang B; Sieberts SK; Peters MA; Domenici E; Schadt EE; Devlin B; Sklar P; Roeder K; Roussos P;
Mol Psychiatry; 2019 Nov; 24(11):1685-1695. PubMed ID: 29740122
[TBL] [Abstract][Full Text] [Related]
11. Super-Enhancer-Mediated RNA Processing Revealed by Integrative MicroRNA Network Analysis.
Suzuki HI; Young RA; Sharp PA
Cell; 2017 Mar; 168(6):1000-1014.e15. PubMed ID: 28283057
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide analysis of enhancer RNA in gene regulation across 12 mouse tissues.
Cheng JH; Pan DZ; Tsai ZT; Tsai HK
Sci Rep; 2015 Jul; 5():12648. PubMed ID: 26219400
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype.
Qin N; Ma Z; Wang C; Zhang E; Li Y; Huang M; Chen C; Zhang C; Fan J; Gu Y; Xu X; Yang L; Wei X; Yin R; Jiang Y; Dai J; Jin G; Xu L; Hu Z; Shen H; Ma H
Theranostics; 2020; 10(24):11264-11277. PubMed ID: 33042282
[No Abstract] [Full Text] [Related]
14. Enforced Activation of Enhancer RNAs In Situ through the dCas9 Synergistic Activation Mediator System.
Liao Z; Lee JH; Krakowiak J; Wang R; Li W
J Vis Exp; 2020 Jun; (160):. PubMed ID: 32568241
[TBL] [Abstract][Full Text] [Related]
15. Current Advances on the Important Roles of Enhancer RNAs in Molecular Pathways of Cancer.
Wang R; Tang Q
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073237
[TBL] [Abstract][Full Text] [Related]
16. Enhancer RNAs in cancer: regulation, mechanisms and therapeutic potential.
Lee JH; Xiong F; Li W
RNA Biol; 2020 Nov; 17(11):1550-1559. PubMed ID: 31916476
[TBL] [Abstract][Full Text] [Related]
17. Single-cell profiling reveals that eRNA accumulation at enhancer-promoter loops is not required to sustain transcription.
Rahman S; Zorca CE; Traboulsi T; Noutahi E; Krause MR; Mader S; Zenklusen D
Nucleic Acids Res; 2017 Apr; 45(6):3017-3030. PubMed ID: 27932455
[TBL] [Abstract][Full Text] [Related]
18. The molecular understanding of super-enhancer dysregulation in cancer.
Yoshino S; Suzuki HI
Nagoya J Med Sci; 2022 May; 84(2):216-229. PubMed ID: 35967935
[TBL] [Abstract][Full Text] [Related]
19. Population-scale study of eRNA transcription reveals bipartite functional enhancer architecture.
Kristjánsdóttir K; Dziubek A; Kang HM; Kwak H
Nat Commun; 2020 Nov; 11(1):5963. PubMed ID: 33235186
[TBL] [Abstract][Full Text] [Related]
20. Implications of Enhancer Transcription and eRNAs in Cancer.
Adhikary S; Roy S; Chacon J; Gadad SS; Das C
Cancer Res; 2021 Aug; 81(16):4174-4182. PubMed ID: 34016622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
